Use of IκB-kinase inhibitors in pain therapy

Details Use of IκB-kinase inhibitors in pain therapy Use of IκB-kinase inhibitors in pain therapy

2003-08-18

2008-12-09

Kwon, Brian-Yong S (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S414000

Reexamination Certificate

active

07462638

ABSTRACT:
The present invention relates to the use of IκB-kinase Inhibitors and methods for the prophylaxis and therapy for treating pain comprising administering such compounds.

REFERENCES:
patent: 6358978 (2002-03-01), Ritzeler et al.
patent: 6627637 (2003-09-01), Ritzeler et al.
patent: 2003/0119820 (2003-06-01), Ritzeler et al.
U.S. Appl. No. 10/642,970, filed Aug. 18, 2003.
U.S. Appl. No. 60/570,146, filed May 12, 2004.
U.S. Appl. No. 10/842,427, filed May 11, 2004.
Hottelet, et al., Development of IkB Kinase Inhibitors As Anti-Inflammatory Therapeutics, Inflammation Research Supplemental, p. 2, (2000), S91, XP009023847.
Yin, et al., The Anti-Inflammatory Agents Aspirin And Salicylate Inhibit The Activity of IkB Kinase-Beta, Nature, MacMillan Journals Ltd. vol. 39615, pp. 77-80, (1998), XP002938591.

Affiliated with

Also associated with

Rating

Use of IκB-kinase inhibitors in pain therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of IκB-kinase inhibitors in pain therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of IκB-kinase inhibitors in pain therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4030903